Timothy M E Davis Selected Research

Body Weight (Weight, Body)

1/2022	Pharmacokinetic properties of the antimalarial combination therapy artemether-lumefantrine in normal-weight, overweight and obese healthy male adults.
5/2021	Efficacy and Safety of Ertugliflozin in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea: A Sub-Study of VERTIS CV.
1/2015	Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in African children with malaria.
1/2014	Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria.
6/2012	Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria.
11/2011	Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.
3/2010	Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy.
3/2006	Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
8/2004	Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy M E Davis Research Topics

Disease

72	Type 2 Diabetes Mellitus (MODY) 01/2024 - 11/2004
62	Malaria 10/2023 - 04/2002
22	Infections 09/2023 - 04/2004
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 07/2009
16	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2022 - 01/2002
15	Vivax Malaria 09/2023 - 04/2002
9	Body Weight (Weight, Body) 01/2022 - 08/2004
8	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 08/2006
7	Parasitemia 12/2014 - 03/2006
6	Albuminuria 03/2024 - 10/2005
6	Coronary Disease (Coronary Heart Disease) 12/2023 - 02/2005
6	Stroke (Strokes) 01/2023 - 10/2005
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2023 - 09/2010
5	Heart Failure 01/2023 - 10/2016
5	Peripheral Arterial Disease 01/2021 - 09/2010
5	Peripheral Nervous System Diseases (PNS Diseases) 07/2019 - 10/2005
4	Diabetic Nephropathies (Diabetic Nephropathy) 05/2023 - 03/2017
4	Myocardial Infarction 01/2023 - 01/2010
4	Overweight 01/2022 - 10/2010
4	Anemia 10/2018 - 04/2010
3	Insulin Resistance 01/2022 - 08/2014
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 01/2007
3	Coma (Comas) 01/2019 - 01/2009
3	Bacterial Meningitis 10/2018 - 09/2011
3	Bacterial Infections (Bacterial Infection) 10/2018 - 03/2012
3	Inflammation (Inflammations) 01/2018 - 01/2007
3	Cognitive Dysfunction 06/2017 - 11/2008
3	Hypertension (High Blood Pressure) 01/2016 - 11/2011
2	Polyneuropathies (Polyneuropathy) 03/2024 - 09/2023
2	Convalescence 10/2023 - 01/2003
2	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 10/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 10/2012
2	Obesity 10/2021 - 10/2010
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 11/2020
2	Dementia (Dementias) 07/2019 - 01/2017
2	Cataract (Cataracts) 01/2019 - 01/2019
2	Pneumonia (Pneumonitis) 10/2018 - 01/2013
2	Hemoglobinopathies 10/2018 - 07/2017
2	Gout 01/2018 - 01/2018

Drug/Important Bio-Agent (IBA)

22	artemisinin (artemisinine)IBA 01/2022 - 02/2005
18	Insulin (Novolin)FDA Link 11/2020 - 11/2004
15	Antimalarials (Antimalarial Agents)IBA 11/2022 - 07/2002
15	Lumefantrine Drug Combination Artemether (Coartem)FDA Link 01/2022 - 09/2007
15	artenimol (dihydroartemisinin)IBA 01/2022 - 01/2002
15	Chloroquine (Aralen)FDA LinkGeneric 10/2019 - 04/2002
13	Blood Glucose (Blood Sugar)IBA 01/2024 - 11/2004
13	ArtesunateIBA 01/2016 - 01/2002
12	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 07/2002
12	CreatinineIBA 01/2020 - 02/2005
9	Biomarkers (Surrogate Marker)IBA 05/2023 - 04/2012
9	Artemether FDA Link 01/2022 - 03/2006
8	AlbuminsIBA 01/2020 - 02/2005
8	Proteins (Proteins, Gene)FDA Link 12/2019 - 04/2004
7	Fenofibrate (CiL)FDA LinkGeneric 01/2024 - 08/2008
7	pyrimethamine drug combination fanasil (Fansidar)FDA Link 10/2019 - 12/2003
7	naphthoquineIBA 10/2017 - 08/2014
7	piperaquineIBA 06/2012 - 12/2002
5	Metformin (Glucophage)FDA LinkGeneric 09/2023 - 04/2008
5	Primaquine FDA Link 09/2023 - 09/2009
5	insulin receptor-related receptor (IRR)IBA 01/2022 - 10/2012
5	Hemoglobins (Hemoglobin)IBA 01/2022 - 04/2010
5	Lumefantrine FDA Link 01/2022 - 03/2010
4	HDL CholesterolIBA 01/2019 - 08/2014
4	Triglycerides (Triacylglycerol)IBA 01/2019 - 02/2005
4	Anti-Bacterial Agents (Antibiotics)IBA 08/2017 - 03/2012
4	Quinine (Quinson)FDA Link 01/2016 - 07/2002
4	AntigensIBA 01/2012 - 04/2002
3	Antihypertensive Agents (Antihypertensives)IBA 03/2024 - 01/2016
3	Uric Acid (Urate)IBA 01/2024 - 01/2018
3	Immunoglobulin G (IgG)IBA 10/2023 - 01/2011
3	AntibodiesIBA 10/2023 - 09/2010
3	Bicarbonates (Hydrogen Carbonate)IBA 10/2023 - 02/2011
3	Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric 09/2023 - 10/2010
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 11/2008
3	LipidsIBA 01/2019 - 10/2010
3	Lactic Acid (Lactate)FDA LinkGeneric 01/2019 - 07/2002
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 09/2009
3	AdiponectinIBA 09/2018 - 06/2017
3	Testosterone (Sustanon)FDA Link 07/2017 - 08/2014
3	Amodiaquine (Camoquin)FDA Link 10/2014 - 03/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2013 - 10/2010
3	CholesterolIBA 10/2012 - 02/2005
3	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 05/2012 - 09/2005
3	DNA (Deoxyribonucleic Acid)IBA 04/2010 - 09/2007
3	Suppositories (Vaginal Suppositories)IBA 04/2007 - 08/2004
2	Antidepressive Agents (Antidepressants)IBA 03/2024 - 10/2010
2	Plasmodium falciparum erythrocyte membrane protein 1IBA 10/2023 - 01/2019
2	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 09/2023 - 01/2014
2	CanagliflozinIBA 05/2023 - 10/2020
2	Retinaldehyde (Retinal)IBA 01/2023 - 12/2020
2	SolutionsIBA 01/2021 - 04/2004
2	Angiotensin Receptor AntagonistsIBA 01/2020 - 11/2008
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2020 - 10/2018
2	Apolipoproteins E (ApoE)IBA 07/2019 - 10/2010
2	ApolipoproteinsIBA 11/2017 - 10/2010

Therapy/Procedure

53	Therapeutics 03/2024 - 07/2002
8	Glycemic Control 01/2024 - 09/2005
4	Surgical Amputation (Amputations) 01/2023 - 10/2012
3	Drug Therapy (Chemotherapy) 12/2018 - 08/2017
2	Complementary Therapies (Alternative Medicine) 08/2020 - 01/2020